Alnylam Pharmaceuticals
The Senior Director, Pathology provides scientific leadership for interpreting and applying clinical pathology data across Alnylam's research and development portfolio. This role involves serving as a subject matter expert to evaluate nonclinical study results, support regulatory submissions, and guide biomarker and translational strategies from discovery through early development. The position requires deep expertise in clinical pathology, strong communication skills, and the ability to mentor team members while collaborating with cross-functional stakeholders.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alnylam Pharmaceuticals.